Hoercher KJ et al. - Status 2 patients, including those delisted, require vigilant surveillance and optimal medical management, implantable cardioverter–defibrillators, and a revised approach to transplantation timing, such that overall salvage is maximized while allocation of scarce organs is optimized.
|